Abstract
REM sleep behavior disorder (RBD) is a potentially injurious parasomnia characterized by dream enactment behavior and polysomnographic REM sleep atonia loss (REM sleep without atonia, RSWA), most commonly seen as a manifestation of an early alpha-synuclein-mediated neurodegenerative disease in older adults. However, RBD has also been reported to evolve following lesions in the brainstem or limbic system. To date, 44 cases of “lesional RBD” have been reported in the literature. Age of lesional RBD onset and male predominance is similar to presumably synuclein-mediated RBD. Lesions to either the left or right dorsal pons, superior medulla, or limbic system appear to be most strongly associated with development of RBD, supporting the localization of REM sleep atonia control to the locus subcoeruleus/sublateral dorsal nucleus (SubC/SLD) of the pons. A variety of etiologies including infarction/encephalomalacia, inflammatory/demyelinating disorders, autoimmune disease, vascular malformation, and neoplasm have been associated with the development of lesional RBD, suggesting lesion location is more important than etiology in the development of RBD. It remains unknown whether brain lesions interact with preexisting covert pontine synuclein deposits that are already present (i.e., whether lesional RBD requires a “two-hit” pathophysiology) or perhaps with other vulnerability factors that could predispose toward RBD development, since lesional RBD is much rarer than pontine lesions in the general population. The development of RBD following either a discrete lesion to the dorsal pontine location of the SubC/SLD or extraaxial lesions exerting mass effect on the brainstem suggests that disruption or disturbance of the SubC/SLD or its afferent/efferent projections to other structures in the REM atonia control network can cause RBD. Lesional RBD may be refractory to pharmacologic treatment with or without continued presence of the lesion, and resolution of RBD following effective treatment of the underlying etiology is variable, likely depending upon the degree of reversibility of damage or possibly due to permanent impact and alteration of REM atonia control networks following disturbance by a lesion even after its resolution. Patients who develop RBD along with focal neurologic deficits or in the context of subacutely evolving syndromic neurologic manifestations of encephalopathy, cognitive, autonomic, or movement disorder impairments should undergo brain magnetic resonance imaging to rule out a structural lesion as the cause of their RBD.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jouvet M, Delorme F. Locus coeruleus et sommeil paradoxal. C R Soc Biol. 1965;159:895–9.
De Barros-Ferreira M, Chodkiewicz JP, Lairy GC, Salzarulo P. Disorganized relations of tonic and phasic events of REM sleep in a case of brain-stem tumour. Electroencephalogr Clin Neurophysiol. 1975;38(2):203–7.
Schenck CH, Bundlie SR, Smith SA, Ettinger MG, Mahowald MW. REM behavior disorder in a 10 year old girl and aperiodic REM and NREM sleep movements in an 8 year old brother. Sleep Res. 1986;15:162.
Schenck CH, Bundlie SR, Ettinger MG, Mahowald MW. Chronic behavioral disorders of human REM sleep: a new category of parasomnia. Sleep. 1986;9(2):293–308.
Iranzo A, Aparicio J. A lesson from anatomy: focal brain lesions causing REM sleep behavior disorder. Sleep Med. 2009;10(1):9–12.
Felix S, Thobois S, Peter-Derex L. Rapid eye movement sleep ҫ disorder symptomatic of a brain stem cavernoma. J Sleep Res. 2016;25(2):211–5.
Fernandez-Arcos A, Iranzo A, Serradell M, Gaig C, Santamaria J. The clinical phenotype of idiopathic rapid eye movement sleep behavior disorder at presentation: a study in 203 consecutive patients. Sleep. 2016;39(1):121–32.
Flanagan EP, Gavrilova RH, Boeve BF, Kumar N, Jelsing EJ, Silber MH. Adult-onset autosomal dominant leukodystrophy presenting with REM sleep behavior disorder. Neurology. 2013;80(1):118–20.
Iranzo A, Graus F, Clover L, Morera J, Bruna J, Vilar C, et al. Rapid eye movement sleep behavior disorder and potassium channel antibody-associated limbic encephalitis. Ann Neurol. 2006;59(1):178–81.
Jianhua C, Xiuqin L, Quancai C, Heyang S, Yan H. Rapid eye movement sleep behavior disorder in a patient with brainstem lymphoma. Intern Med. 2013;52(5):617–21.
Kimura K, Tachibana N, Kohyama J, Otsuka Y, Fukazawa S, Waki R. A discrete pontine ischemic lesion could cause REM sleep behavior disorder. Neurology. 2000;55(6):894–5.
Lai YY, Hsieh KC, Nguyen D, Peever J, Siegel JM. Neurotoxic lesions at the ventral mesopontine junction change sleep time and muscle activity during sleep: an animal model of motor disorders in sleep. Neuroscience. 2008;154(2):431–43.
Limousin N, Dehais C, Gout O, Heran F, Oudiette D, Arnulf I. A brainstem inflammatory lesion causing REM sleep behavior disorder and sleepwalking (parasomnia overlap disorder). Sleep Med. 2009;10(9):1059–62.
Mathis J, Hess CW, Bassetti C. Isolated mediotegmental lesion causing narcolepsy and rapid eye movement sleep ҫ disorder: a case evidencing a common pathway in narcolepsy and rapid eye movement sleep ҫ disorder. J Neurol Neurosurg Psychiatry. 2007;78(4):427–9.
McCarter SJ, Tippmann-Peikert M, Sandness DJ, Flanagan EP, Kantarci K, Boeve BF, et al. Neuroimaging-evident lesional pathology associated with REM sleep behavior disorder. Sleep Med. 2015;16(12):1502–10.
Peter A, Hansen ML, Merkl A, Voigtlander S, Bajbouj M, Danker-Hopfe H. REM sleep behavior disorder and excessive startle reaction to visual stimuli in a patient with pontine lesions. Sleep Med. 2008;9(6):697–700.
Plazzi G, Montagna P. Remitting REM sleep behavior disorder as the initial sign of multiple sclerosis. Sleep Med. 2002;3(5):437–9.
Provini F, Vetrugno R, Pastorelli F, Lombardi C, Plazzi G, Marliani AF, et al. Status dissociatus after surgery for tegmental ponto-mesencephalic cavernoma: a state-dependent disorder of motor control during sleep. Mov Disord. 2004;19(6):719–23.
Reynolds TQ, Roy A. Isolated cataplexy and REM sleep behavior disorder after pontine stroke. J Clin Sleep Med. 2011;7(2):211–3.
Sabater L, Gaig C, Gelpi E, Bataller L, Lewerenz J, Torres-Vega E, et al. A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study. Lancet Neurol. 2014;13(6):575–86.
St Louis EK, McCarter SJ, Boeve BF, Silber MH, Kantarci K, Benarroch EE, et al. Lesional REM sleep behavior disorder localizes to the dorsomedial pons. Neurology. 2014;83(20):1871–3.
Tang WK, Hermann DM, Chen YK, Liang HJ, Liu XX, Chu WC, et al. Brainstem infarcts predict REM sleep behavior disorder in acute ischemic stroke. BMC Neurol. 2014;14:88.
Tippmann-Peikert M, Boeve BF, Keegan BM. REM sleep behavior disorder initiated by acute brainstem multiple sclerosis. Neurology. 2006;66(8):1277–9.
Tribl GG, Bor-Seng-Shu E, Trindade MC, Lucato LT, Teixeira MJ, Barbosa ER. Wilson’s disease presenting as rapid eye movement sleep behavior disorder: a possible window to early treatment. Arq Neuropsiquiatr. 2014;72(9):653–8.
Zambelis T, Paparrigopoulos T, Soldatos CR. REM sleep ҫ disorder associated with a neurinoma of the left pontocerebellar angle. J Neurol Neurosurg Psychiatry. 2002;72(6):821–2.
Zhang X, Wang LN. REM sleep behavior disorder in a patient with pontine stroke. Sleep Med. 2009;10(1):143–6.
Geddes MR, Tie Y, Gabrieli JD, McGinnis SM, Golby AJ, Whitfield-Gabrieli S. Altered functional connectivity in lesional peduncular hallucinosis with REM sleep behavior disorder. Cortex. 2016;74:96–106.
Compta Y, Iranzo A, Santamaria J, Casamitjana R, Graus F. REM sleep behavior disorder and narcoleptic features in anti-Ma2-associated encephalitis. Sleep. 2007;30(6):767–9.
Honorat JA, Komorowski L, Josephs KA, Fechner K, St Louis EK, Hinson SR, et al. IgLON5 antibody: neurological accompaniments and outcomes in 20 patients. Neurol Neuroimmunol Neuroinflamm. 2017;4(5):e385.
Hogl B, Heidbreder A, Santamaria J, Graus F, Poewe W. IgLON5 autoimmunity and abnormal ҫs during sleep. Lancet. 2015;385(9977):1590.
Dauvilliers Y, Siegel JM, Lopez R, Torontali ZA, Peever JH. Cataplexy—clinical aspects, pathophysiology and management strategy. Nat Rev Neurol. 2014;10(7):386–95.
Luppi PH, Clement O, Sapin E, Garcia SV, Peyron C, Fort P. Animal models of REM dysfunctions: what they tell us about the cause of narcolepsy and RBD? Arch Ital Biol. 2014;152(2–3):118–28.
Henriques PSA, Pratesi R. Sleep apnea and REM sleep behavior disorder in patients with Chiari malformations. Arq Neuropsiquiatr. 2008;66(2B):344–9.
McCarter SJ, Boswell CL, St Louis EK, Dueffert LG, Slocumb N, Boeve BF, et al. Treatment outcomes in REM sleep behavior disorder. Sleep Med. 2013;14(3):237–42.
Gomez-Choco MJ, Iranzo A, Blanco Y, Graus F, Santamaria J, Saiz A. Prevalence of restless legs syndrome and REM sleep behavior disorder in multiple sclerosis. Mult Scler. 2007;13(6):805–8.
Iranzo A, Tolosa E, Gelpi E, Molinuevo JL, Valldeoriola F, Serradell M, et al. Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep ҫ disorder: an observational cohort study. Lancet Neurol. 2013;12(5):443–53.
Schenck CH, Boeve BF, Mahowald MW. Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series. Sleep Med. 2013;14(8):744–8.
Iranzo A, Valldeoriola F, Lomena F, Molinuevo JL, Serradell M, Salamero M, et al. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep ҫ disorder: a prospective study. Lancet Neurol. 2011;10(9):797–805.
Fraigne JJ, Torontali ZA, Snow MB, Peever JH. REM sleep at its Core—circuits, neurotransmitters, and pathophysiology. Front Neurol. 2015;6:123.
Luppi PH, Clement O, Fort P. Paradoxical (REM) sleep genesis by the brainstem is under hypothalamic control. Curr Opin Neurobiol. 2013;23(5):786–92.
Peever J, Luppi PH, Montplaisir J. Breakdown in REM sleep circuitry underlies REM sleep behavior disorder. Trends Neurosci. 2014;37(5):279–88.
Brooks PL, Peever JH. Glycinergic and GABA(A)-mediated inhibition of somatic motoneurons does not mediate rapid eye movement sleep motor atonia. J Neurosci. 2008;28(14):3535–45.
Brooks PL, Peever JH. Identification of the transmitter and receptor mechanisms responsible for REM sleep paralysis. J Neurosci. 2012;32(29):9785–95.
Carroll C, Landau ME. Effects of pontine lesions on REM sleep. Curr Neurol Neurosci Rep. 2014;14(7):460.
Luppi PH, Gervasoni D, Verret L, Goutagny R, Peyron C, Salvert D, et al. Paradoxical (REM) sleep genesis: the switch from an aminergic-cholinergic to a GABAergic-glutamatergic hypothesis. J Physiol Paris. 2006;100(5–6):271–83.
Soja PJ, Lopez-Rodriguez F, Morales FR, Chase MH. The postsynaptic inhibitory control of lumbar motoneurons during the atonia of active sleep: effect of strychnine on motoneuron properties. J Neurosci. 1991;11(9):2804–11.
Valencia Garcia S, Libourel PA, Lazarus M, Grassi D, Luppi PH, Fort P. Genetic inactivation of glutamate neurons in the rat sublaterodorsal tegmental nucleus recapitulates REM sleep ҫ disorder. Brain. 2017;140(Pt 2):414–28.
Weng FJ, Williams RH, Hawryluk JM, Lu J, Scammell TE, Saper CB, et al. Carbachol excites sublaterodorsal nucleus neurons projecting to the spinal cord. J Physiol. 2014;592(Pt 7):1601–17.
Hendricks JC, Morrison AR, Mann GL. Different behaviors during paradoxical sleep without Atonia depend on pontine lesion site. Brain Res. 1982;239(1):81–105.
Acknowledgments
The project described was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant Number 1 UL1 RR024150-01. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Disclosures
No off-label medication use.
The project described was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant Number 1 UL1 RR024150-01. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
SJ McCarter reports no disclosures.
EK St. Louis reports that he receives research support from the Mayo Clinic Center for Translational Science Activities (CTSA), supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant Number 1 UL1 RR024150-01.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
McCarter, S.J., St. Louis, E.K. (2019). Lesional RBD. In: Schenck, C., Högl, B., Videnovic, A. (eds) Rapid-Eye-Movement Sleep Behavior Disorder. Springer, Cham. https://doi.org/10.1007/978-3-319-90152-7_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-90152-7_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-90151-0
Online ISBN: 978-3-319-90152-7
eBook Packages: MedicineMedicine (R0)